Back
Apellis Pharmaceuticals Vs. Match Group Industry Stock Comparison
Sell
44
APLS
Apellis Pharmaceuticals
Last Price:
29.26
Seasonality Move:
22.1%
Sell
33
MTCH
Match Group
Last Price:
30.19
Seasonality Move:
7.35%
Sell
44
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.74. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Match Group (MTCH)
is a Sell
Is Match Group a Buy, Sell or Hold?
- The current Match Group [MTCH] share price is $31.11. The Score for MTCH is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MTCH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.74
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTCH Stock Price Chart
What is Match Group's stock price today?
-
The Match Group share price today is $31.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTCH is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | 1111604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.02 - 28.18) | Buy |
| Bollinger Bands (100): | (29.8 - 39.68) | Sell |
MTCH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 25.99 | Sell |
| Chaikin Money Flow: | -12597076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.67 - 38.45) | Sell |
| Bollinger Bands (100): | (32.53 - 37.77) | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.07 | Buy |
| 20-day SMA: | 27.64 | Buy |
| 50-day SMA: | 31.4 | Sell |
| 200-day SMA: | 44.39 | Sell |
| 8-day EMA: | 28.2 | Buy |
| 20-day EMA: | 28.26 | Buy |
| 50-day EMA: | 30.71 | Sell |
| 200-day EMA: | 40.74 | Sell |
MTCH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.96 | Sell |
| 20-day SMA: | 36.97 | Sell |
| 50-day SMA: | 36.81 | Sell |
| 200-day SMA: | 34.42 | Sell |
| 8-day EMA: | 35.63 | Sell |
| 20-day EMA: | 36.49 | Sell |
| 50-day EMA: | 36.46 | Sell |
| 200-day EMA: | 35.6 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.93 per share.
Match Group Earnings Growth & MTCH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.47 per share.
Apellis Pharmaceuticals Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Match Group Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||